REGN News
Regeneron Pharmaceuticals, Inc.
$951.19
-$8.22(-0.86%)
67
Overall
80
Value
66
Tech
57
Quality
Market Cap
$98.40B
Volume
1.03M
52W Range
$591.52 - $991.73
Target Price
$950.47
REGN news: the latest Regeneron Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest REGN News
- Regeneron Updates Obesity Drug Study as Investors Await ResultsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 12, 2026
- Regeneron Advances ALN-CIDEB Into Phase 3 Liver Disease StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 5, 2026
- Regeneron and Sanofi Update Long-Term Pediatric Dupixent StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Nov 3, 2026
- Regeneron (REGN) Receives a Rating Update from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Nov 2, 2026
- Analysts Conflicted on These Healthcare Names: AbbVie (ABBV), Regeneron (REGN) and Stoke Therapeutics (STOK)TipRanks Newsroom · Nov 2, 2026
- Regeneron Earnings Call Highlights Explosive Growth, Deep PipelineTipRanks Auto-Generated Newsdesk · Nov 1, 2026
- Regeneron Expands Skin Cancer Pipeline With New Cemiplimab Combo TrialTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 30, 2026
- Sanofi and Regeneron Advance Dupixent Coformulation in Key Phase 1 StudyTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 29, 2026
- The Week That Was, The Week Ahead: Macro and Markets, October 25Ran Melamed · Oct 25, 2026
- Regeneron (REGN) Receives a Rating Update from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
- Amprius, Viking, Regeneron, Ionis, Crispr Trending With AnalystsTipRanks Weekend Auto-Generated Newsdesk · Oct 17, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | REGN | $951.19 | -0.9% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Regeneron Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW